Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic Cancer
Clinical trial NCT00670748 · TERMINATED
Trial details
- NCT number
- NCT00670748
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-29
- Primary completion
- 2016-06-29
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.